Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)

NANot yet recruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 1, 2030

Study Completion Date

June 1, 2030

Conditions
Head and Neck Squamous Cell Carcinoma HNSCC
Interventions
OTHER

Remote symptoms moniotring

Participants in the intervention arm will use Resilience PRO, a mobile phone application regularly asking participants about their symptoms. For clinically important symptoms, an alert is sent to the care team that can incorporate that information to timely adjust the care of the participants.

Trial Locations (2)

Unknown

Centre Henri Becquerel, Rouen

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Resilience

INDUSTRY

lead

Centre Henri Becquerel

OTHER

NCT07190755 - Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC) | Biotech Hunter | Biotech Hunter